Declaration of competing financial interests : Unifying themes in host defence effector polypeptides : Nature Reviews Microbiology

Jump to main content
Jump to navigation
nature.com homepage
Publications A-Z index
Browse by subject

My account
E-alert sign up
Register
Subscribe

From the following article:

Unifying themes in host defence effector polypeptides

Michael R. Yeaman & Nannette Y. Yount

Nature Reviews Microbiology 5, 727-740 (September 2007)

doi:10.1038/nrmicro1744

Declaration: Michael R. Yeaman is an equity shareholder of NovaDigm Therapeutics, which develops strategies to address the threat of antibiotic-resistant infections and immune dysfunction. NovaDigm Therapeutics provided no financial support for this study. His research has received funding from Pfizer and Amgen but neither provided financial support for this particular study.